• 1. An integrated microfluidic 3D tumor system for parallel and high-throughput chemotherapy evaluation?
  Dan Liu,Rui Hu,Zhongchao Huang,Meilin Sun,Kai Han Analyst, 2020,145, 6447-6455
• 2. An autonomous self-optimizing flow machine for the synthesis of pyridine–oxazoline (PyOX) ligands?
  Eric Wimmer,Daniel Cortés-Borda,Solène Brochard,Elvina Barré,Charlotte Truchet,Fran?ois-Xavier Felpin React. Chem. Eng., 2019,4, 1608-1615
• 3. An approach to asymmetric synthesis of β-aryl alanines by Pd(0)-catalyzed cross-coupling and cyanate-to-isocyanate rearrangement?
  Piotr Szcze?niak,Sebastian Stecko RSC Adv., 2015,5, 30882-30888
• 4. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acid esters
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Benzoic acid esters

Methyl 2-amino-4-(trifluoromethyl)benzoate (CAS No. 61500-87-6): A Comprehensive Overview

Methyl 2-amino-4-(trifluoromethyl)benzoate (CAS No. 61500-87-6) is a significant compound in the field of pharmaceutical chemistry, known for its versatile applications in drug development and synthetic organic chemistry. This compound, characterized by its unique structural features, has garnered considerable attention due to its potential in various biochemical pathways and therapeutic interventions.

The molecular structure of Methyl 2-amino-4-(trifluoromethyl)benzoate consists of a benzoate core substituted with an amino group at the 2-position and a trifluoromethyl group at the 4-position. This specific arrangement imparts distinct chemical properties that make it a valuable intermediate in the synthesis of more complex molecules. The presence of the trifluoromethyl group, in particular, enhances the lipophilicity and metabolic stability of derivatives, which is a crucial factor in pharmaceutical design.

In recent years, there has been a growing interest in exploring the pharmacological properties of compounds containing the benzoate moiety. Research has shown that benzoate derivatives exhibit a wide range of biological activities, including anti-inflammatory, antimicrobial, and anticonvulsant effects. The introduction of fluorine atoms into these structures often modulates their pharmacokinetic profiles, making them more suitable for therapeutic applications.

Methyl 2-amino-4-(trifluoromethyl)benzoate has been extensively studied as a precursor in the synthesis of various pharmacologically active agents. For instance, it serves as a key intermediate in the preparation of nonsteroidal anti-inflammatory drugs (NSAIDs) and other therapeutic compounds. The amino group at the 2-position allows for further functionalization through reductive amination or diazotization reactions, enabling the creation of more complex scaffolds.

One of the most compelling aspects of Methyl 2-amino-4-(trifluoromethyl)benzoate is its role in the development of novel antibiotics. The trifluoromethyl group enhances the binding affinity of compounds to bacterial enzymes, thereby improving their efficacy against resistant strains. This has led to several ongoing studies aimed at identifying new derivatives with enhanced antibacterial properties.

The compound's utility extends beyond pharmaceutical applications. In synthetic organic chemistry, it is valued for its role as a building block in multi-step syntheses. Its stability under various reaction conditions makes it an ideal candidate for constructing more intricate molecular architectures. Additionally, its compatibility with a wide range of catalysts and reagents allows chemists to explore diverse synthetic pathways.

Recent advancements in computational chemistry have further highlighted the importance of Methyl 2-amino-4-(trifluoromethyl)benzoate. Molecular modeling studies have revealed insights into its interactions with biological targets, providing valuable information for drug design. These computational approaches have enabled researchers to predict the binding affinity and specificity of derivatives before conducting expensive experimental trials.

The environmental impact of using Methyl 2-amino-4-(trifluoromethyl)benzoate as an intermediate has also been examined. Studies have shown that proper handling and disposal protocols can minimize any potential ecological risks associated with its use. As sustainable chemistry becomes increasingly important, efforts are being made to develop greener synthetic routes that reduce waste and energy consumption.

In conclusion, Methyl 2-amino-4-(trifluoromethyl)benzoate (CAS No. 61500-87-6) is a multifaceted compound with significant implications in pharmaceutical research and industrial applications. Its unique structural features and biological activities make it a valuable asset in drug development, while its synthetic versatility ensures its continued relevance in organic chemistry. As research progresses, we can expect to see even more innovative uses for this compound emerging from both academic and industrial laboratories.

• 22235-25-2(Methyl 3-amino-5-(trifluoromethyl)benzoate)
• 167760-75-0(Methyl 4-amino-3-(trifluoromethyl)benzoate)
• 126541-82-0(Methyl 3-amino-4-(trifluoromethyl)benzoate)
• 154057-15-5(Ethyl 3-amino-4-(trifluoromethyl)benzoate)
• 147494-56-2(Methyl 2-amino-6-(trifluoromethyl)benzoate)
• 65568-55-0(Ethyl 2-amino-4-trifluoromethylbenzoate)
• 117324-58-0(Methyl 2-amino-5-(trifluoromethyl)benzoate)
• 1108668-05-8(Ethyl 2-amino-5-(trifluoromethyl)benzoate)
• 64321-95-5(Methyl 2-amino-3-(trifluoromethyl)benzoate)
• 872624-53-8(Methyl 2-amino-5-methyl-4-(trifluoromethyl)benzoate)